Article
The X factor: skewing X inactivation towards cancer.
Cell - 29 Jun 2007
Medema René H, Burgering Boudewijn M Th
Abstract excerpt
Increased expression of the epidermal growth factor receptor HER-2/ErbB2 is frequently observed in breast cancer and is targeted by the anticancer drug Herceptin. Now, Zuo et al. (2007) reveal that an X-linked gene encoding the transcription factor FOXP3 is a breast cancer tumor suppressor that represses expression of HER2/ErbB2.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
